SGLT2 Inhibitors Act Independently of SGLT2 to Confer Benefit for HFrEF in Mice

被引：4

|

作者：

Berger, Justin H. ^{[1
,2
]}

Matsuura, Timothy R. ^{[2
]}

Bowman, Caitlyn E. ^{[2
,3
]}

Taing, Renee ^{[2
]}

Patel, Jiten ^{[2
]}

Lai, Ling ^{[2
]}

Leone, Teresa C. ^{[2
]}

Reagan, Jeffrey D. ^{[4
]}

Haldar, Saptarsi M. ^{[4
]}

Arany, Zoltan ^{[2
]}

Kelly, Daniel P. ^{[1
,2
]}

机构：

[1] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA USA

[2] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Dept Med, Philadelphia, PA USA

[3] Williams Coll, Dept Biol, Williamstown, MA USA

[4] Amgen Res, Cardiometab Disorders, South San Francisco, CA USA

来源：

CIRCULATION RESEARCH | 2024年 / 135卷 / 05期

基金：

美国国家卫生研究院;

关键词：

drug therapy; experimental animal models; heart failure; systolic; ketosis; ventricular remodeling;

D O I：

10.1161/CIRCRESAHA.124.324823

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：632 / 634

页数：3

相关论文

共 50 条

[1] Cardiovascular benefit of SGLT2 inhibitors
Mohebi, Reza
Januzzi, James L.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2022, 59 (03) : 142 - 155
[2] SGLT2 INHIBITORS
Brito, M.
CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
[3] SGLT2 inhibitors
Dardi, I.
Kouvatsos, T.
Jabbour, S. A.
BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39
[4] SGLT2 inhibitors
Steyn, Lynda
SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
[5] SGLT2 Inhibitors: Benefit/Risk Balance
André J. Scheen
Current Diabetes Reports, 2016, 16
[6] SGLT2 Inhibitors: Benefit/Risk Balance
Scheen, Andre J.
CURRENT DIABETES REPORTS, 2016, 16 (10)
[7] Ketoacidosis with SGLT2 Inhibitors
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1471): : 94 - 94
[8] SGLT2 inhibitors and cardioprotection
Chen, S.
Wang, Q.
Christodoulou, A.
Mylonos, N.
Bakker, D.
Wakker, V.
Hollmann, M. W.
Weber, N. C.
Coronel, R.
Christoffels, V.
Andreadou, I.
Zuurbier, C. J.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53
[9] SGLT2 inhibitors: are they safe?
Filippas-Ntekouan, Sebastian
Filippatos, Theodosios D.
Elisaf, Moses S.
POSTGRADUATE MEDICINE, 2018, 130 (01) : 72 - 82
[10] From Pump to Periphery: the Graded Benefit of SGLT2 Inhibitors in HFrEF and Progressive Vascular Disease
Correa, Ashish
JOURNAL OF CARDIAC FAILURE, 2023, 29 (10) : 1355 - 1357

← 1 2 3 4 5 →